21 May 2013
Keywords: India, CDSCO, Cisapride, Phenylpropanolamine, Human placenta extracts
Article | 25 November 2010
India’s Central Drugs Standard Control Organisation (CDSCO), the apex drug regulator, may soon ban the production and sale ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 November 2010
20 May 2013
© 2013 thepharmaletter.com